Eiko LifeSciences Limited (BOM:540204)
India
· Delayed Price · Currency is INR 49.87
-0.29 (-0.58%)
At close: Apr 28, 2026
Eiko LifeSciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 756 | 674 | 717 | 636 | 403 | 303 | Upgrade
|
| Market Cap Growth | 16.44% | -5.99% | 12.74% | 57.59% | 33.32% | 680.30% | Upgrade
|
| Enterprise Value | 692 | 647 | 676 | 680 | 398 | 297 | Upgrade
|
| Last Close Price | 49.87 | 52.33 | 51.70 | 66.24 | 42.03 | 68.64 | Upgrade
|
| PE Ratio | 16.02 | 31.99 | 95.35 | 82.68 | 57.15 | 49.25 | Upgrade
|
| PS Ratio | 1.66 | 1.79 | 2.57 | 3.47 | 1.59 | 2.52 | Upgrade
|
| PB Ratio | 1.27 | 1.18 | 1.41 | 2.16 | 1.41 | 2.42 | Upgrade
|
| P/TBV Ratio | 1.29 | 1.19 | 1.41 | 2.16 | 1.41 | 2.42 | Upgrade
|
| P/FCF Ratio | - | - | - | 15.89 | - | - | Upgrade
|
| P/OCF Ratio | - | 23.04 | - | 15.05 | - | - | Upgrade
|
| EV/Sales Ratio | 1.52 | 1.72 | 2.42 | 3.71 | 1.57 | 2.48 | Upgrade
|
| EV/EBITDA Ratio | 10.47 | 23.43 | 41.90 | 71.21 | 30.27 | 51.85 | Upgrade
|
| EV/EBIT Ratio | 12.34 | 31.96 | 71.12 | 211.29 | 52.86 | 58.08 | Upgrade
|
| EV/FCF Ratio | - | - | - | 17.00 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.05 | - | 0.00 | 0.16 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.16 | 1.00 | - | 0.06 | 3.52 | 3.18 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.01 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | -0.16 | -0.26 | -0.02 | 0.15 | -0.38 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.10 | -3.27 | -8.27 | -0.58 | 3.35 | -8.22 | Upgrade
|
| Net Debt / FCF Ratio | - | 1.22 | 1.80 | -0.14 | -0.56 | 5.72 | Upgrade
|
| Asset Turnover | - | 0.63 | 0.67 | 0.56 | 0.99 | 0.84 | Upgrade
|
| Inventory Turnover | - | 7.16 | 11.84 | 5.06 | 8.19 | 6.49 | Upgrade
|
| Quick Ratio | - | 3.60 | 17.60 | 6.44 | 0.80 | 2.62 | Upgrade
|
| Current Ratio | - | 5.25 | 20.56 | 7.76 | 2.24 | 2.70 | Upgrade
|
| Return on Equity (ROE) | - | 4.31% | 1.88% | 2.65% | 3.43% | 9.01% | Upgrade
|
| Return on Assets (ROA) | - | 2.13% | 1.42% | 0.61% | 1.83% | 2.23% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.84% | 3.47% | 2.19% | 0.78% | 2.76% | 7.52% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 3.40% | 1.90% | 1.10% | 2.60% | 4.00% | Upgrade
|
| Earnings Yield | 5.61% | 3.13% | 1.05% | 1.21% | 1.75% | 2.03% | Upgrade
|
| FCF Yield | - | -10.94% | -10.36% | 6.29% | -19.54% | -2.73% | Upgrade
|
| Buyback Yield / Dilution | -7.22% | -26.37% | -5.41% | -25.30% | -104.48% | - | Upgrade
|
| Total Shareholder Return | -7.22% | -26.37% | -5.41% | -25.30% | -104.48% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.